FibroBiologics (FBLG) Competitors $0.57 +0.02 (+3.62%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$0.57 +0.00 (+0.03%) As of 08/12/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBLG vs. ZURA, SAVA, HLVX, COYA, CHRS, MGNX, CLYM, PLRX, ANIX, and ONCYShould you be buying FibroBiologics stock or one of its competitors? The main competitors of FibroBiologics include Zura Bio (ZURA), Cassava Sciences (SAVA), HilleVax (HLVX), Coya Therapeutics (COYA), Coherus Oncology (CHRS), MacroGenics (MGNX), Climb Bio (CLYM), Pliant Therapeutics (PLRX), Anixa Biosciences (ANIX), and Oncolytics Biotech (ONCY). These companies are all part of the "pharmaceutical products" industry. FibroBiologics vs. Its Competitors Zura Bio Cassava Sciences HilleVax Coya Therapeutics Coherus Oncology MacroGenics Climb Bio Pliant Therapeutics Anixa Biosciences Oncolytics Biotech Zura Bio (NASDAQ:ZURA) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Is ZURA or FBLG more profitable? Zura Bio's return on equity of -42.84% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Zura BioN/A -42.84% -35.22% FibroBiologics N/A -710.25%-118.02% Do analysts recommend ZURA or FBLG? Zura Bio currently has a consensus target price of $14.33, suggesting a potential upside of 875.06%. FibroBiologics has a consensus target price of $13.00, suggesting a potential upside of 2,161.66%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts plainly believe FibroBiologics is more favorable than Zura Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zura Bio 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Which has preferable earnings and valuation, ZURA or FBLG? Zura Bio is trading at a lower price-to-earnings ratio than FibroBiologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZura BioN/AN/A-$45.39M-$0.70-2.10FibroBiologicsN/AN/A-$11.16M-$0.36-1.60 Does the media refer more to ZURA or FBLG? In the previous week, FibroBiologics had 7 more articles in the media than Zura Bio. MarketBeat recorded 12 mentions for FibroBiologics and 5 mentions for Zura Bio. Zura Bio's average media sentiment score of 0.84 beat FibroBiologics' score of 0.68 indicating that Zura Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zura Bio 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FibroBiologics 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of ZURA or FBLG? 61.1% of Zura Bio shares are held by institutional investors. 22.1% of Zura Bio shares are held by insiders. Comparatively, 20.8% of FibroBiologics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, ZURA or FBLG? Zura Bio has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.74, suggesting that its stock price is 174% less volatile than the S&P 500. SummaryZura Bio beats FibroBiologics on 7 of the 13 factors compared between the two stocks. Get FibroBiologics News Delivered to You Automatically Sign up to receive the latest news and ratings for FBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBLG vs. The Competition Export to ExcelMetricFibroBiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.24M$2.99B$5.49B$9.69BDividend YieldN/A2.29%4.64%4.14%P/E Ratio-1.6019.9630.4025.31Price / SalesN/A344.97444.45101.55Price / CashN/A40.7837.7258.50Price / Book28.747.658.306.01Net Income-$11.16M-$54.75M$3.26B$265.10M7 Day Performance7.16%0.95%1.53%1.39%1 Month Performance-8.66%8.12%3.73%2.43%1 Year Performance-69.43%10.97%41.02%24.74% FibroBiologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBLGFibroBiologics3.5096 of 5 stars$0.57+3.6%$13.00+2,161.7%-68.6%$23.24MN/A-1.6010ZURAZura Bio3.8283 of 5 stars$1.46-2.7%$14.33+881.7%-56.4%$102.56MN/A-2.093Positive NewsSAVACassava Sciences2.7706 of 5 stars$2.29+8.0%$54.50+2,279.9%-89.5%$102.41MN/A-1.5330Upcoming EarningsHLVXHilleVax1.7829 of 5 stars$2.07+1.5%$2.00-3.4%+29.6%$102.29MN/A-0.9620Earnings ReportUpcoming EarningsHigh Trading VolumeCOYACoya Therapeutics2.082 of 5 stars$6.34+4.1%$16.50+160.3%+16.1%$101.86M$3.69M-5.936News CoverageEarnings ReportCHRSCoherus Oncology4.4029 of 5 stars$0.87-1.1%$4.68+439.6%-37.3%$101.77M$266.96M-0.77330MGNXMacroGenics4.4065 of 5 stars$1.64+3.8%$5.33+225.2%-56.1%$99.68M$152.43M-1.84430CLYMClimb Bio3.2936 of 5 stars$1.70+17.2%$9.00+429.4%N/A$97.99MN/A-0.719News CoverageEarnings ReportHigh Trading VolumePLRXPliant Therapeutics3.989 of 5 stars$1.70+7.6%$13.31+683.1%-85.8%$96.99M$1.58M-0.4790Earnings ReportAnalyst ForecastANIXAnixa Biosciences3.5206 of 5 stars$3.26+8.3%$9.00+176.1%-4.7%$96.96M$210K-8.585ONCYOncolytics Biotech2.1362 of 5 stars$0.88-10.8%$4.33+390.7%-9.3%$96.43MN/A-3.0530Earnings ReportGap Down Related Companies and Tools Related Companies ZURA Competitors SAVA Competitors HLVX Competitors COYA Competitors CHRS Competitors MGNX Competitors CLYM Competitors PLRX Competitors ANIX Competitors ONCY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBLG) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access